Related Experiment Video
Updated: Mar 20, 2026

Massive Pontine Hemorrhage by Dual Injection of Autologous Blood
Published on: May 29, 2021
Management of massive diffuse alveolar hemorrhage in a child with systemic lupus erythematosus
Dai Kimura1, Samir Shah2, Mario Briceno-Medina3
1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Le Bonheur Children's Hospital/University of Tennessee Health Science Center, 50 N. Dunlap St, TN Memphis, 38103 USA.
Insights
Diffuse alveolar hemorrhage (DAH) in systemic lupus erythematosus (SLE) is rare and dangerous. This case shows successful management of severe DAH in a young SLE patient using ECMO, surgery, and intensive medical therapy.
Area of Science:
- Rheumatology
- Pulmonology
- Critical Care Medicine
Background:
- Systemic lupus erythematosus (SLE) can manifest with severe pulmonary complications.
- Diffuse alveolar hemorrhage (DAH) is a rare but life-threatening SLE manifestation.
Observation:
- A 14-year-old female with SLE presented with hypoxia and shock.
- The patient experienced severe alveolar hemorrhage.
Findings:
- Successful management involved extracorporeal membrane oxygenation (ECMO).
- Emergent pulmonary lobectomy was performed.
- Treatment included high-dose methylprednisolone, cyclophosphamide, IV immunoglobulin, and plasmapheresis.
Implications:
- This case highlights a multidisciplinary approach for managing severe SLE-related DAH.
- Aggressive treatment strategies, including ECMO and surgery, can be life-saving.
- Early recognition and intervention are crucial for favorable outcomes in SLE-DAH.
Abstract:
Diffuse alveolar hemorrhage (DAH) from systemic lupus erythematosus (SLE) is a rare but potentially life-threatening condition. We report the case of a 14-year-old female with SLE who developed hypoxia and shock secondary to severe alveolar hemorrhage. She was successfully managed by placement on extracorporeal membrane oxygenation (ECMO) followed by emergent pulmonary lobectomy and medical treatment including high-dose methylprednisolone, cyclophosphamide, intravenous immunoglobulin, and plasmapheresis.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...